Compare and Contrast the Use of SGLT2 Inhibitors and GLP1 Agonists: A Case Study is organized by American College of Cardiology (ACC).
The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American College of Cardiology designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
While offering the credits noted above, this program is not intended to provide extensive training or certification in the field.
The American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC Provider number 0019).
The ACCF designates this educational activity for a maximum of 0.25 continuing nursing education contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
While offering the CNE contact hours noted above, this activity is not intended to provide extensive training or certification in the field.
In this case study, you will compare and contrast the use of SGLT2 Inhibitors and GLP1 agonists when applied to a case-scenario.
Upon completing this activity, learners should be able to:
• Utilize knowledge of SGLT2 Inhibitors and GLP1 Agonists to solve a case-based scenario
This activity is primarily intended for general adult cardiologists and the cardiovascular care team (nurse practitioners, registered nurses, physician assistants and pharmacists). Endocrinologists and primary care physicians may also benefit from this education.